68Ga-FAPI PET/CT 与 18F-FDG PET/CT 显像 IgG4 相关疾病的比较
该前瞻性队列研究纳入 26 例 IgG4 相关疾病患者,全部行 68Ga-FAPI 与 18F-FDG PET/CT。在 136 个受累器官中,68Ga-FAPI 较 18F-FDG 额外检出 18 个(13.2%)受累器官,涉及 13 例(50.0%)患者。68Ga-FAPI 在胰腺、胆管/肝脏和泪腺的阳性率更高,在胰腺、胆管/肝脏和唾液腺的摄取值显著更高(P < 0.01),但 18F-FDG 呈「翻转」摄取的淋巴结累及未见 68Ga-FAPI 摄取。作者认为 68Ga-FAPI 可能是评估 IgG4 相关疾病有前景的显像剂。
要点
- 68Ga-FAPI 较 18F-FDG 额外检出 18 个(13.2%)受累器官,涉及 13 例(50.0%)患者。
- 68Ga-FAPI 在胰腺、胆管/肝脏和泪腺的阳性率高于 18F-FDG。
- 胰腺、胆管/肝脏和唾液腺中 68Ga-FAPI 摄取值显著高于 18F-FDG(P < 0.01)。
核心结论
- 作者认为 68Ga-FAPI 可能是评估 IgG4 相关疾病有前景的显像剂。
研究设计与样本
- 前瞻性队列研究,纳入 26 例 IgG4 相关疾病患者,全部行 68Ga-FAPI 与 18F-FDG PET/CT。
- 比较受累器官的 PET/CT 阳性率与摄取值。
主要发现
- 26 例患者共 136 个受累器官中,68Ga-FAPI PET/CT 较 18F-FDG PET/CT 额外检出 18 个(13.2%)受累器官,涉及 13 例(50.0%)患者。
- 68Ga-FAPI PET/CT 在胰腺、胆管/肝脏和泪腺的受累检出阳性率高于 18F-FDG PET/CT。
- 胰腺、胆管/肝脏和唾液腺的匹配病灶中,68Ga-FAPI 摄取值显著高于 18F-FDG(P < 0.01)。
- 18F-FDG 呈翻转摄取的淋巴结累及未见 68Ga-FAPI 摄取。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IgG4-related disease (RD) is characterized by lymphoplasmacytic infiltration enriched in IgG4-positive plasma cells and variable degrees of fibrosis with a characteristic storiform pattern. Since fibrosis is an important feature of IgG4-RD, we performed a prospective cohort study to evaluate the performance of 68Ga-fibroblast activation protein inhibitor (FAPI), a recently introduced PET agent targeting fibroblast activation protein, in IgG4-RD. Methods: Twenty-six patients with IgG4-RD were recruited. All patients underwent both 68Ga-FAPI and 18F-FDG PET/CT. The positive rates of the PET/CT scans in the involved organs and the uptake values were compared. Results: In a total of 136 involved organs in the 26 patients, 68Ga-FAPI PET/CT additionally detected 18 (13.2%) involved organs in 13 (50.0%) patients, compared with 18F-FDG PET/CT. 68Ga-FAPI PET/CT had a higher positive rate than 18F-FDG PET/CT in detecting involvement in the pancreas, bile duct/liver, and lacrimal gland. 68Ga-FAPI also demonstrated significantly higher uptake than 18F-FDG in the matched disease in the pancreas, bile duct/liver, and salivary gland (P < 0.01). However, lymph node involvement with flip-flop uptake of 18F-FDG did not accumulate 68Ga-FAPI. Conclusion:68Ga-FAPI might be a promising imaging agent for the assessment of IgG4-RD.
引用
- Luo Y, Pan Q, Yang H, et al. Fibroblast Activation Protein-Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT. J Nucl Med. 2020. PMID: 32513902. doi:10.2967/jnumed.120.244723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。